NAGE

Niagen Bioscience, Inc. Common Stock

53 hedge funds and large institutions have $33.1M invested in Niagen Bioscience, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+11
Holders Change %
+26.19%
% of All Funds
1.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
14
Reduced
8
Closed
9
Calls
$6.84M
Puts
Net Calls
+$6.84M
Net Calls Change
+$6.84M
Name Holding Trade Value Shares
Change
Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$4K +$3.96K +583 +9,717%
QT
52
Quantbot Technologies
New York
$2K +$2K +500 New
MAM
53
Meeder Asset Management
Ohio
$1K -$1.69K -425 -63%
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$47
VF
55
Virtu Financial
New York
-$272K -63,189 Closed
Bank of Montreal
56
Bank of Montreal
Ontario, Canada
-$156K -36,422 Closed
PHS
57
Pekin Hardy Strauss
Illinois
-$150K -35,000 Closed
ECM
58
Element Capital Management
New York
-$139K -32,351 Closed
Squarepoint
59
Squarepoint
New York
-$129K -30,000 Closed
TSS
60
Two Sigma Securities
New York
-$55K -12,813 Closed
Group One Trading
61
Group One Trading
Illinois
-$17K -4,000 Closed
PFO
62
Pathstone Family Office
New Jersey
-$13K -3,000 Closed
TRCT
63
Tower Research Capital (TRC)
New York
-$5K -1,159 Closed